文献速递妇科生殖医学

肠道菌群失调来源的β-葡萄糖醛酸酶促进子宫内膜异位症的发展

Gut dysbiosis-derived β-glucuronidase promotes the development of endometriosis.
PubMed 文献 · Fertil Steril · 2023-05-12

本研究通过16S rRNA测序分析35例子宫内膜异位症患者和30例对照的粪便样本及小鼠模型,发现两组α和β多样性无差异,但β-葡萄糖醛酸酶在肠道和宫骶韧带病灶中表达高于正常子宫内膜(p<0.01),可促进子宫内膜基质细胞增殖和迁移,并促进M0向M2巨噬细胞转化,在小鼠模型中增加病灶数量、体积和巨噬细胞数量。结论认为β-葡萄糖醛酸酶通过直接或间接导致巨噬细胞功能障碍促进子宫内膜异位症发展,具有潜在治疗意义。

要点

  • 子宫内膜异位症患者与对照的肠道菌群α和β多样性无差异。
  • β-葡萄糖醛酸酶在肠道和宫骶韧带病灶中表达高于正常子宫内膜(p<0.01)。
  • β-葡萄糖醛酸酶促进子宫内膜基质细胞增殖和迁移,并促进M0向M2巨噬细胞转化。

核心结论

  • β-葡萄糖醛酸酶通过直接或间接导致巨噬细胞功能障碍促进子宫内膜异位症发展,其致病作用的明确具有潜在治疗意义。

研究设计与样本

  • 对35例子宫内膜异位症患者和30例对照的粪便样本及小鼠模型进行16S rRNA测序,以评估肠道菌群变化并识别影响子宫内膜异位症发展的分子因素。
  • 在子宫内膜异位症C57BL6小鼠模型中进行体内实验,并在体外验证β-葡萄糖醛酸酶水平及其在子宫内膜异位症发展中的作用。
  • 收集了50个肠道子宫内膜异位病灶、50个宫骶韧带病灶、50个无病灶样本和50个正常子宫内膜的石蜡包埋切片。

主要发现

  • 子宫内膜异位症患者与对照之间α和β多样性无差异。
  • 免疫组化分析显示β-葡萄糖醛酸酶在肠道病灶和宫骶韧带病灶中的表达高于正常子宫内膜(p<0.01)。
  • β-葡萄糖醛酸酶在CCK-8、Transwell和伤口愈合实验中促进子宫内膜基质细胞的增殖和迁移。
  • 肠道病灶和宫骶韧带病灶中巨噬细胞水平(尤其是M2)高于对照,且β-葡萄糖醛酸酶促进M0向M2转化。
  • 经β-葡萄糖醛酸酶处理的巨噬细胞条件培养基促进子宫内膜基质细胞增殖和迁移;β-葡萄糖醛酸酶增加小鼠子宫内膜异位症模型中病灶的数量、体积和病灶内巨噬细胞数量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the role of gut dysbiosis-derived β-glucuronidase (GUSB) in the development of endometriosis (EMs). DESIGN: 16S rRNA sequencing of stool samples from women with (n = 35) or without (n = 30) endometriosis and from a mouse model was conducted to assess gut microbiome changes and identify molecular factors influencing the development of endometriosis. Experiments in vivo in an endometriosis C57BL6 mouse model and in vitro verified the level of GUSB and its role in the development of EMs. SETTING: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University; Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases. PATIENT(S): Women of reproductive age with a histological diagnosis of endometriosis were enrolled in the endometriosis group (n = 35) and infertile or healthy age-matched women who had undergone a gynecological or radiological examination in the control group (n = 30). Fecal and blood samples were taken the day before surgery. Paraffin-embedded sections from 50 bowel endometriotic lesions, 50 uterosacral lesions, 50 samples without lesions, and 50 normal endometria were collected. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Changes in the gut microbiome of patients with EMs and mice and the effect of β-glucuronidase on the proliferation and invasion of endometrial stromal cells and the development of endometriotic lesions were assessed. RESULT(S): No difference in α and β diversity was found between patients with EMs and controls. Immunohistochemistry analysis showed higher β-glucuronidase expression in bowel lesions and uterosacral ligament lesions than in the normal endometrium (p<0.01). β-Glucuronidase promoted the proliferation and migration of endometrial stromal cells during cell counting kit-8, Transwell, and wound-healing assays. Macrophage levels, especially M2, were higher in bowel lesions and uterosacral ligament lesions than in controls, and β-glucuronidase promoted the M0 to M2 transition. Medium conditioned by β-glucuronidase-treated macrophages promoted endometrial stromal cell proliferation and migration. β-Glucuronidase increased the number and volume of endometriotic lesions and number of macrophages present in lesions in the mouse EMs model. CONCLUSION(S): This β-Glucuronidase promoted EMs development directly or indirectly by causing macrophage dysfunction. The characterization of the pathogenic role of β-glucuronidase in EMs has potential therapeutic implications.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Wei Y, Tan H, Yang R, et al. Gut dysbiosis-derived β-glucuronidase promotes the development of endometriosis. Fertil Steril. 2023. PMID: 37178109. doi:10.1016/j.fertnstert.2023.03.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。